Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.44 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 3/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | VDR | P11473 | 1/20 | 0.35 |
| ▸ | CNR1 | P21554 | 4/20 | 0.35 |
| ▸ | CNR2 | P34972 | 4/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.34 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.34 |
| ▸ | GMNN | O75496 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | THPO | P40225 | 1/20 | 0.34 |
| ▸ | MTOR | P42345 | 1/20 | 0.34 |
| ▸ | BLM | P54132 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28718183 | 1.00 | USP2 (0.44) | USP2PLA2G2CHTTMAPTMEN1 | |
| SCHEMBL4204839 | 1.00 | USP2 (0.44) | USP2PLA2G2CHTTMAPTMEN1 | |
| SCHEMBL28823669 | 1.00 | USP2 (0.44) | USP2PLA2G2CHTTMAPTMEN1 | |
| SCHEMBL28869452 | 1.00 | USP2 (0.44) | USP2PLA2G2CHTTMAPTMEN1 | |
| SCHEMBL28668489 | 1.00 | USP2 (0.44) | USP2PLA2G2CHTTMAPTMEN1 | |
| SCHEMBL29064941 | 1.00 | USP2 (0.44) | USP2PLA2G2CHTTMAPTMEN1 | |
| SCHEMBL4204713 | 1.00 | USP2 (0.44) | USP2PLA2G2CHTTMAPTMEN1 | |
| SCHEMBL21006 | 0.98 | USP2 (0.42) | USP2PLA2G2CHTTMAPTMEN1 | |
| SCHEMBL4712788 | 0.95 | USP2 (0.43) | USP2PLA2G2CHTTMAPTMEN1 | |
| SCHEMBL4398138 | 0.91 | MEN1 (0.40) | USP2PLA2G2CHTTMAPTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1363599-B1 | MILD MOISTURIZING LIQUIDS WITH SOAP-LIKE RINSE FEEL | UNILEVER PLC (GB) | 2012-12-19 | — | — | EP | claimed |
| EP-2031974-A1 | FATTY ACID TRIGLYCERIDES FOR MAKING BIOCOMPATIBLE COATINGS | Ziscoat N.V. (BE) | 2009-03-11 | — | — | EP | claimed |
| WO-2007131802-A1 | FATTY ACID TRIGLYCERIDES FOR MAKING BIOCOMPATIBLE COATINGS | ZISCOAT NV (BE) | 2007-11-22 | — | — | WO | claimed |
| EP-3870144-B1 | LIPOPHILIC TRANSPORT PARTICLES FOR COSMETIC OR PHARMACEUTICAL ACTIVE INGREDIENTS | IOI OLEO GMBH (DE) | 2026-05-27 | — | — | EP | disclosed |
| EP-3870228-B1 | HOT-MELT COATING PROCESS | IOI OLEO GMBH (DE) | 2024-01-03 | — | — | EP | disclosed |
| WO-2023186288-A1 | DEFOAMING FORMULATIONS CONTAINING TRIACYLGLYCERIDES AND POLYDIORGANOSILOXANES AS ADDITIVES | WACKER CHEMIE AG (DE) | 2023-10-05 | — | — | WO | disclosed |
| EP-2953687-B1 | PERSONAL CARE COMPOSITIONS THAT INCLUDE ENROBED SUGAR | UNILEVER PLC (GB) | 2016-09-21 | — | — | EP | disclosed |
| US-20150374592-A1 | PERSONAL CARE COMPOSITIONS THAT INCLUDE ENROBED SUGAR | CONOPCO, INC., D/B/A UNILEVER (US) | 2015-12-31 | — | — | US | disclosed |
| EP-2953687-A1 | PERSONAL CARE COMPOSITIONS THAT INCLUDE ENROBED SUGAR | Unilever PLC (GB) | 2015-12-16 | — | — | EP | disclosed |
| US-9056208-B2 | Personal care compositions that include enrobed sugar | CONOPCO, INC., D/B/A UNILEVER | 2015-06-16 | — | — | US | disclosed |
| WO-2014122046-A1 | PERSONAL CARE COMPOSITIONS THAT INCLUDE ENROBED SUGAR | UNILEVER PLC (GB) | 2014-08-14 | — | — | WO | disclosed |
| WO-2002074252-A2 | MILD MOISTURIZING LIQUIDS WITH SOAP-LIKE RINSE FEEL | UNILEVER PLC (GB) | 2002-09-26 | — | — | WO | disclosed |
| WO-2002067888-A1 | PERSONAL WASH COMPOSITIONS CONTAINING PARTICLE-IN-OIL DISPERSION | UNILEVER PLC (GB) | 2002-09-06 | — | — | WO | disclosed |
| WO-2002067892-A2 | PROCESS FOR MAKING MILD MOISTURIZING LIQUIDS CONTAINING LARGE OIL DROPLET | UNILEVER PLC (GB) | 2002-09-06 | — | — | WO | disclosed |
| US-6395691-B1 | MIXTURE CONTAINING SURFACTANTS | UNILEVER HOME & PERSONAL CARE USA DIVISION OF CONOPCO, INC. | 2002-05-28 | — | — | US | disclosed |
| US-6395690-B1 | MIXING SURFACTANT, OIL AND POLYMER | UNILEVER HOME & PERSONAL CARE USA DIVISION OF CONOPCO, INC. | 2002-05-28 | — | — | US | disclosed |
| US-20020034537-A1 | Cationic diagnostic, imaging and therapeutic agents associated with activated vascular sites | MEDIGENE ONCOLOGY GMBH (DE) | 2002-03-21 | — | — | US | disclosed |
| WO-2001082899-A2 | CATIONIC DIAGNOSTIC, IMAGING AND THERAPEUTIC AGENTS ASSOCIATED WITH ACTIVATED VASCULAR SITES | MBT MUNICH BIOTECHNOLOGY AG (DE) | 2001-11-08 | — | — | WO | disclosed |
| US-5154841-A | Cyclizing a polyamine with a fatty acid, ester, acyl halide or anhydride, followed by catalytic esterification with fatty acid ester or glycerides; titanium or tin alkoxides, salts, halides or alkyl halide as catalysts | THE PROCTER & GAMBLE COMPANY (US) | 1992-10-13 | — | — | US | disclosed |
| EP-0375029-A2 | Process for preparing substituted imidazoline fabric conditioning compounds | THE PROCTER & GAMBLE COMPANY (US) | 1990-06-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150374592-A1 | PERSONAL CARE COMPOSITIONS THAT INCLUDE ENROBED SUGAR | CUTA, POLR1C, TTR | USP2 1538/4885PLA2G2C 4173/4885HTT 22/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.